Flagship KRAS mutant cancers are pancreatic, colorectal, lung, and urogenital adenocarcinomas [3]. It is known that approximately 30-50% of colorectal tumors have a mutated KRAS gene and approximately 5-10% of cases have a mutated BRAF gene [4]. This evidence concerns the gene KRAS and colorectal neoplasm.